Evasion of Type I Interferon by SARS-CoV-2

Xia, Hongjie, Cao, Zengguo, Xie, Xuping, Zhang, Xianwen, Chen, John Yun-Chung, Wang, Hualei, Menachery, Vineet D., Rajsbaum, Ricardo +1 more·2020·Cell Reports
DOI 10.1016/j.celrep.2020.108234

Cited by (958)

Items 401–500 of 958

  1. Innate Immunity Evasion Strategies of Highly Pathogenic Coronaviruses: SARS-CoV, MERS-CoV, and SARS-CoV-2
    Jinyan Li, Zhijian Zhou, Qiong Wang, Qingnan He, Mingyi Zhao, Ye Qiu, Xing‐Yi Ge · 2021 · Frontiers in Microbiology
  2. The Inhibition of RNA Viruses by Amaryllidaceae Alkaloids: Opportunities for the Development of Broad‐Spectrum Anti‐Coronavirus Drugs
    Shen H. Tan, Martin G. Banwell, Wen‐Cai Ye, Ping Lan, Lorenzo V. White · 2022 · Chemistry - An Asian Journal
  3. Executable network of SARS-CoV-2-host interaction predicts drug combination treatments
    Rowan S. M. Howell, Matthew A. Clarke, Ann‐Kathrin Reuschl, Tianyi Chen, Sean Abbott-Imboden, Mervyn Singer, David M. Lowe, Clare L. Bennett, Benny Chain, Clare L. Jolly et al. · 2022 · npj Digital Medicine
  4. Immune Responses of a Novel Bi-Cistronic SARS-CoV-2 DNA Vaccine Following Intradermal Immunization With Suction Delivery
    Moonsup Jeong, Sagar B. Kudchodkar, Areum Gil, Bohyun Jeon, Gee Ho Park, Youngran Cho, Hyojin Lee, Mi Sun Cheong, Won‐Il Kim, Yun-Ho Hwang et al. · 2022 · Frontiers in Virology
  5. Mycobacterium tuberculosis and SARS-CoV-2 co-infections: The knowns and unknowns
    Kim Lam Chiok, Neeraj Dhar, Arinjay Banerjee · 2023 · iScience
  6. The translational landscape of SARS-CoV-2 and infected cells
    Maritza Puray‐Chavez, Nakyung Lee, Kasyap Tenneti, Yiqing Wang, Hung R. Vuong, Yating Liu, Amjad Horani, Tao Huang, Sean P. Gunsten, James Brett Case et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  7. Gene Set Enrichment Analysis Reveals That Fucoidan Induces Type I IFN Pathways in BMDC
    Suyoung Choi, Sol A Jeon, Bu Yeon Heo, Ju‐Gyeong Kang, Yunju Jung, Pham Thi Thuy Duong, Ik‐Chan Song, Jeong‐Hwan Kim, Seon‐Young Kim, Jaeyul Kwon · 2022 · Nutrients
  8. Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches
    Shahrzad Ahmadi, Mahsa Bazargan, Reza Elahi, Abdolreza Esmaeilzadeh · 2022 · Molecular Immunology
  9. Engagement of the G3BP2-TRIM25 Interaction by Nucleocapsid Protein Suppresses the Type I Interferon Response in SARS-CoV-2-Infected Cells
    Zening Yang, Jing Li, Jiali Li, Huiwen Zheng, Heng Li, Qingrun Lai, Yanli Chen, Li Qin, Yuanyuan Zuo, Lei Guo et al. · 2022 · Vaccines
  10. SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense
    Xiaohui Ju, Ziqiao Wang, Pengcheng Wang, Wenlin Ren, Yanying Yu, Yu Yin, Bin Yuan, Jingwei Song, Xiaochun Zhang, Yu Zhang et al. · 2023 · mBio
  11. Nanoscopic Elucidation of Spontaneous Self-Assembly of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Open Reading Frame 6 (ORF6) Protein
    Goro Nishide, Keesiang Lim, Maiki Tamura, Akiko Kobayashi, Qingci Zhao, Masaharu Hazawa, Toshio Ando, N. Nishida, Richard Wing-Chuen Wong · 2023 · The Journal of Physical Chemistry Letters
  12. Essential contribution of the JAK/STAT pathway to carcinogenesis, lytic infection of herpesviruses and pathogenesis of COVID‑19 (Review)
    Wen-Kai Li, Yunjing Zhuang, Songjun Shao, Pankaj Trivedi, Biying Zheng, Guoliang Huang, Zhiwei He, Xiangning Zhang · 2024 · Molecular Medicine Reports
  13. SARS-CoV-2 S protein disrupts the formation of ISGF3 complex through conserved S2 subunit to antagonize type I interferon response
    Wenjia Ni, Wenkang Li, Zeng Cai, Wenhua Guo, Yucheng Zheng, Yongliang Zhao, Zhixuan Wu, Simeng Liang, Jiajie Ye, Xiao Guo et al. · 2024 · Journal of Virology
  14. Beta interferons as immunotherapy in multiple sclerosis: a new outlook on a classic drug during the COVID-19 pandemic
    Laura Dumitrescu, Athanasios I. Papathanasiou, Catalina Coclitu, Cris S. Constantinescu, Bogdan Ovidiu Popescu, Radu Tănăsescu · 2021 · QJM
  15. Immunology of SARS-CoV-2 infections and vaccines
    Dominik Schenten, Deepta Bhattacharya · 2021 · Advances in immunology
  16. Myeloid dysregulation and therapeutic intervention in COVID-19
    Runxia Gu, Tianyang Mao, Lu Qiao, Tina Tianjiao Su, Jun Wang · 2021 · Seminars in Immunology
  17. Type-I interferons in the immunopathogenesis and treatment of Coronavirus disease 2019
    Hossein Khorramdelazad, Mohammad Hossein Kazemi, Maryam Azimi, Azin Aghamajidi, Ali Zarezadeh Mehrabadi, Faezeh Shahba, Nazanin Aghamohamadi, Reza Falak, Fatemeh Faraji, Reza Jafari · 2022 · European Journal of Pharmacology
  18. Targeting CTP Synthetase 1 to Restore Interferon Induction and Impede Nucleotide Synthesis in SARS-CoV-2 Infection
    Youliang Rao, Tingyu Wang, Chao Qin, Bianca Espinosa, Qizhi Liu, Arunika I. Ekanayake, Jun Xue Zhao, Ali Can Savas, Shu Jie Zhang, Mehrnaz Zarinfar et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  19. Autophagy and evasion of the immune system by SARS-CoV-2. Structural features of the non-structural protein 6 from wild type and Omicron viral strains interacting with a model lipid bilayer
    Bignon, Emmanuelle, Marazzi, Marco, Grandemange, Stéphanie, Monari, Antonio · 2022 · Chemical Science
  20. SARS-CoV-2 innate immune recognition and implications for respiratory health
    Vandana Anang, Pankaj Kumar, Jamaluddin Pracha, Richard Seonghun Nho, Ana Lucia Mora, Mauricio M. Rojas, Kymberly M. Gowdy, Jacob S. Yount, Joseph S. Bednash, Jeffrey Craig Horowitz et al. · 2025 · Cytokine & Growth Factor Reviews
  21. SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression
    Hosni A. M. Hussein, Ali A. Thabet, Ahmed A. Wardany, Ahmed M. El-Adly, Mohamed E. Ali, Mohamed E. A. Hassan, Mohamed A. B. Abdeldayem, Abdul-Rahman M. A. Mohamed, Ali Sobhy, Mohamed A. El‐Mokhtar et al. · 2024 · Virology Journal
  22. From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2
    Anoop Kumar, Prajna Tripathi, Prashant Kumar, Ritu Shekhar, R. Pathak · 2024 · Vaccines
  23. Host factors of SARS-CoV-2 in infection, pathogenesis, and long-term effects
    Yu Zhang, Shihan Chen, Yan Tian, Xianghui Fu · 2024 · Frontiers in Cellular and Infection Microbiology
  24. Gut microbe–host interactions in post-COVID syndrome: a debilitating or restorative partnership?
    Torsten P. M. Scheithauer, Roy C. Montijn, Arnout Mieremet · 2024 · Gut Microbes
  25. Rationale for COVID-19 Treatment by Nebulized Interferon-β-1b–Literature Review and Personal Preliminary Experience
    Aurélien Mary, Lucie Hénaut, Pierre-Yves Macq, Louise Badoux, Arnaud Cappe, Thierry Porée, Myriam Eckes, Hervé Dupont, Michel Brazier · 2020 · Frontiers in Pharmacology
  26. Coronavirus, the King Who Wanted More Than a Crown: From Common to the Highly Pathogenic SARS-CoV-2, Is the Key in the Accessory Genes?
    Nathalie Chazal · 2021 · Frontiers in Microbiology
  27. Mutational Landscape and Interaction of SARS-CoV-2 with Host Cellular Components
    Mansi Srivastava, Dwight Hall, Okiemute Beatrice Omoru, Hunter Mathias Gill, Sarah Smith, Sarath Chandra Janga · 2021 · Microorganisms
  28. From COVID-19 to Sarcoidosis: How Similar Are These Two Diseases?
    Min Zhao, Chang Tian, Shan Cong, Xin Di, Ke Wang · 2022 · Frontiers in Immunology
  29. COVID-19 Biogenesis and Intracellular Transport
    Mironov Aa, Maksim A. Savin, Galina V. Beznoussenko · 2023 · International Journal of Molecular Sciences
  30. Unveiling the role of PUS7-mediated pseudouridylation in host protein interactions specific for the SARS-CoV-2 RNA genome
    Roberto Giambruno, Elsa Zacco, Camilla Ugolini, Andrea Vandelli, Logan Mulroney, Manfredi D’Onghia, Bianca Giuliani, Elena Criscuolo, Matteo Castelli, Nicola Clementi et al. · 2023 · Molecular Therapy — Nucleic Acids
  31. Interferon Control of Human Coronavirus Infection and Viral Evasion: Mechanistic Insights and Implications for Antiviral Drug and Vaccine Development
    Xuesen Zhao, Danying Chen, Xinglin Li, Lauren E. Griffith, Jinhong Chang, Ping An, Ju‐Tao Guo · 2022 · Journal of Molecular Biology
  32. The Evolutionary Dance between Innate Host Antiviral Pathways and SARS-CoV-2
    Saba Roghiyh Aliyari, Natalie M. Quanquin, Olivier Pernet, Shilei Zhang, Lulan Wang, Genhong Cheng · 2022 · Pathogens
  33. Synergistic interactions of repurposed drugs that inhibit Nsp1, a major virulence factor for COVID-19
    Hung‐Teh Kao, Andrew J. W. Orry, Michael G. Palfreyman, Barbara Porton · 2022 · Scientific Reports
  34. Conjunctival epithelial cells resist productive SARS-CoV-2 infection
    Robert M. Jackson, Catherine F. Hatton, Jarmila Stremenova Spegarova, Μαρία Γεωργίου, Joseph Collin, Emily Stephenson, Bernard Verdon, Iram J. Haq, Rafiqul Hussain, Jonathan M Coxhead et al. · 2022 · Stem Cell Reports
  35. Evidence of recurrent selection of mutations commonly found in SARS-CoV-2 variants of concern in viruses infecting immunocompromised patients
    Livia Ramos Goes, Juliana Domett Siqueira, Marianne Monteiro Garrido, Brunna M. Alves, Claudia Cicala, James A. Arthos, João P. B. Viola, Marcelo Alves Soares · 2022 · Frontiers in Microbiology
  36. Pulmonary fibrosis in COVID-19: mechanisms, consequences and targets
    Steven O’Reilly · 2023 · QJM
  37. Porcine deltacoronavirus nucleocapsid protein antagonizes JAK-STAT signaling pathway by targeting STAT1 through KPNA2 degradation
    Yating Hu, Chenlin Hao, Donghan Wang, Meng Guo, Hongyan Chu, Xiaohui Jin, Shaopo Zu, Xueyan Ding, Honglei Zhang, Hui Hu · 2024 · Journal of Virology
  38. Mechanisms of Gut-Related Viral Persistence in Long COVID
    Philip McMillan, Anthony J. Turner, Bruce D. Uhal · 2024 · Viruses
  39. A Novel Toolkit of SARS-CoV-2 Sub-Genomic Replicons for Efficient Antiviral Screening
    Maximilian Erdmann, Peter A. C. Wing, Isobel Webb, Maia Kavanagh Williamson, Tuksin Jearanaiwitayakul, Edward Sullivan, James Bazire, Iart Luca Shytaj, Jane A. McKeating, David A. Matthews et al. · 2025 · Viruses
  40. IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide
    Bruno J. de Andrade Silva, Paul A. Krogstad, Rosane M. B. Teles, Priscila R. Andrade, Jacob Rajfer, Monica G. Ferrini, Otto O. Yang, Barry R. Bloom, Robert L. Modlin · 2023 · Frontiers in Immunology
  41. Review of Ribosome Interactions with SARS-CoV-2 and COVID-19 mRNA Vaccine
    Jiao Wei, Ai‐Min Hui · 2022 · Life
  42. Human phospho‐signaling networks of SARS‐CoV‐2 infection are rewired by population genetic variants
    Diogo Vieira da Silva Pellegrina, Alexander T. Bahcheli, Michał Krassowski, Jüri Reimand · 2022 · Molecular Systems Biology
  43. A snapshot of protein trafficking in SARS‐CoV‐2 infection
    Vibhu Ranjan Prasad, Ralf F. W. Bartenschlager · 2022 · Biology of the Cell
  44. The Role of Ubiquitin-Proteasome System in the Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus-2 Disease
    Fikadu Seyoum · 2023 · International Journal of Inflammation
  45. ORF3c is expressed in SARS‐CoV‐2‐infected cells and inhibits innate sensing by targeting MAVS
    Martin Müller, Alexandra Herrmann, Shigeru Fujita, Keiya Uriu, Carolin Kruth, Adam Patrick Strange, Jan Eric Kolberg, Markus Schneider, Jumpei Ito, Marcel A. Müller et al. · 2023 · EMBO Reports
  46. The Interplay Between Coronavirus and Type I IFN Response
    Wenxiang Xue, Chan Ding, Kun Qian, Ying Liao · 2022 · Frontiers in Microbiology
  47. Substitution of S179P in the Lyssavirus Phosphoprotein Impairs Its Interferon Antagonistic Function
    Zongmei Wang, Yueming Yuan, Yuan Zhang, Chengguang Zhang, Baokun Sui, Jianqing Zhao, Ming Zhou, Huanchun Chen, Zhen Fang Fu, Ling Zhao · 2022 · Journal of Virology
  48. Mechanisms of impairment of interferon production by SARS-CoV-2
    Huy‐Dung Hoang, Parisa Naeli, Tommy Alain, Seyed Mehdi Jafarnejad · 2023 · Biochemical Society Transactions
  49. Coronavirus 2′-O-methyltransferase: A promising therapeutic target
    Craig Schindewolf, Vineet D. Menachery · 2023 · Virus Research
  50. Enpatoran in COVID ‐19 pneumonia: Safety and efficacy results from a phase II randomized trial
    John E. McKinnon, Joel M. Santiaguel, Cláudia Murta de Oliveira, Dongzi Yu, Mukhy Khursheed, Flavie Moreau, Lena Klopp‐Schulze, Jamie V. Shaw, Sanjeev Roy, Amy H. Kao et al. · 2023 · Clinical and Translational Science
  51. Amino acid substitution L232F in non-structural protein 6 identified as a possible human-adaptive mutation in clade B MERS coronaviruses
    Ray T. Y. So, Daniel K. W. Chu, Kenrie P. Y. Hui, Chris Ka Pun Mok, Marcus Ho-Hin Shum, Sumana Sanyal, John Malcolm Nicholls, John C. W. Ho, Man-chun Cheung, Ka‐Chun Ng et al. · 2023 · Journal of Virology
  52. The HIF transcription network exerts innate antiviral activity in neurons and limits brain inflammation
    Ensieh Farahani, Line Sinnathamby Reinert, Ryo Narita, Manutea Christophe Serrero, Morten Kelder Skouboe, Demi van der Horst, Sonia Assil, Bao‐cun Zhang, Marie Beck Iversen, Eugenio Gutiérrez‐Jiménez et al. · 2024 · Cell Reports
  53. The IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infection
    José Javier Fernández, Arturo Marín, Romel Rosales, Rebekah Penrice-Randal, Petra Mlčochová, Yolanda Álvarez, Fernando Villalón‐Letelier, Soner Yildiz, Enrique Pérez-Riesgo, Raveen Rathnasinghe et al. · 2024 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  54. Molecular determinants of cross-species transmission in emerging viral infections
    Arthur Wickenhagen, Sarah van Tol, Vincent Jacobus Munster · 2024 · Microbiology and Molecular Biology Reviews
  55. TRIM56 restricts Coxsackievirus B infection by mediating the ubiquitination of viral RNA-dependent RNA polymerase 3D
    Yao Wang, Yanyan Dong, Tian Luan, Yang Chen, Lexun Lin, Siwei Li, Danxiang Feng, Jianwei Wei, Yanru Fei, Guangtian Wang et al. · 2024 · PLoS Pathogens
  56. SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor
    Cuiling Zhang, Qiwei Jiang, Zirui Liu, Nan Li, Zhuo Hao, Gaojie Song, Dapeng Li, Minghua Chen, Lisen Lin, Yan Liu et al. · 2024 · Journal of Virology
  57. The comprehensive SARS-CoV-2 ‘hijackome’ knowledge base
    Huuskonen, Sini, Liu, Xiaonan, Pöhner, Ina, Redchuk, Taras, Salokas, Kari, Lundberg, Rickard, Maljanen, Sari, Belik, Milja, Reinholm, Arttu, Kolehmainen, Pekka et al. · 2024 · Cell Discovery
  58. A Conservative Replacement in the Transmembrane Domain of SARS-CoV-2 ORF7a as a Putative Risk Factor in COVID-19
    Andrei Lobiuc, Daniel Șterbuleac, Olga Adriana Căliman-Sturdza, Mihai Dimian, Mihai Covașă · 2021 · Biology
  59. SARS-CoV-2 Virology
    Yijia Li, Jonathan Z. Li · 2022 · Infectious Disease Clinics of North America
  60. Mutations in the nonstructural proteins of SARS-CoV-2 may contribute to adverse clinical outcome in patients with COVID-19
    Takaya Ichikawa, Shiho Torii, Hikoyu Suzuki, Akio Takada, Satoshi Suzuki, Masahide Nakajima, A. Tampo, Y. Kakinoki · 2022 · International Journal of Infectious Diseases
  61. Interaction of HDAC2 with SARS-CoV-2 NSP5 and IRF3 Is Not Required for NSP5-Mediated Inhibition of Type I Interferon Signaling Pathway
    Nenavath Gopal Naik, See-Chi Lee, Beatriz H. S. Veronese, Zhe Ma, Zsolt Tóth · 2022 · Microbiology Spectrum
  62. A neonatal mouse model characterizes transmissibility of SARS-CoV-2 variants and reveals a role for ORF8
    Bruno A. Rodriguez-Rodriguez, Grace O. Ciabattoni, Ralf Duerr, Ana M. Valero-Jimenez, Stephen T. Yeung, Keaton M. Crosse, Austin R. Schinlever, Lucie Bernard, Joaquin Rodriguez Galvan, Marisa E. McGrath et al. · 2023 · Nature Communications
  63. Parallel use of human stem cell lung and heart models provide insights for SARS-CoV-2 treatment
    Rajeev Rudraraju, Matthew J. Gartner, Jessica Anne Neil, Elizabeth S. Stout, Joseph Chen, Elise J. Needham, Michael See, Charley Mackenzie-Kludas, Leo Lee, Mingyang Wang et al. · 2023 · Stem Cell Reports
  64. SADS‐CoV nsp1 inhibits the IFN‐β production by preventing TBK1 phosphorylation and inducing CBP degradation
    Yingjie Xiang, Chunxiao Mou, Kaichuang Shi, Xiang Chen, Xia Meng, Wenbin Bao, Zhenhai Chen · 2023 · Journal of Medical Virology
  65. SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
    Ralf Duerr, Keaton M. Crosse, Ana M. Valero-Jimenez, Meike Dittmann · 2021 · Microorganisms
  66. Interferon β, an enhancer of the innate immune response against SARS-CoV-2 infection
    Suresh Kumar Kali, Peter Dröge, Priyatharshini Murugan · 2021 · Microbial Pathogenesis
  67. COVID-19: Are We Facing Secondary Pellagra Which Cannot Simply Be Cured by Vitamin B3?
    Renata Novak Kujundžić · 2022 · International Journal of Molecular Sciences
  68. Blockade of SARS-CoV-2 infection in vitro by highly potent PI3K-α/mTOR/BRD4 inhibitor
    Arpan Acharya, Kabita Pandey, Michellie Thurman, Kishore B. Challagundala, Kendra R. Vann, Tatiana G. Kutateladze, Guillermo A. Morales, Donald L. Durden, Siddappa N. Byrareddy · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Rapid expansion of SARS-CoV-2 variants of concern is a result of adaptive epistasis
    Michael R. Garvin, Erica T. Prates, Jonathon Romero, Ashley Cliff, Joao Gabriel Felipe Machado Gazolla, Monica Pickholz, Mirko Pavicic, Daniel Jacobson · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  70. NEUROCOV/PSYCCOV: Neuropsychiatric Phenomena in COVID-19 - Exposing Their Hidden Essence and Warning against Iatrogenesis
    Luiz Gonzaga Francisco de Assis Barros D’Elia Zanella · 2021 · Journal of Infectious Diseases and Epidemiology
  71. Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets
    Tao Yang, Si Chun Wang, Linyan Ye, Yasen Maimaitiyiming, Hua Naranmandura · 2023 · Expert Opinion on Drug Discovery
  72. Cellular nucleic acid-binding protein restricts SARS-CoV-2 by regulating interferon and disrupting RNA–protein condensates
    Yongzhi Chen, Xuqiu Lei, Zhaozhao Jiang, Fiachra Humphries, Krishna Mohan Parsi, Nicholas Mustone, Irene Ramos, Tinaye Mutetwa, Ana Fernández-Sesma, René Maehr et al. · 2023 · Proceedings of the National Academy of Sciences
  73. Circulation of SARS-CoV-2 Variants among Children from November 2020 to January 2022 in Trieste (Italy)
    Maria Dolci, Lucia Signorini, Carolina Cason, Giuseppina Campisciano, Paolo Kunderfranco, Elena Pariani, Cristina Galli, Vincenzo Petix, Pasquale Ferrante, Serena Delbue et al. · 2022 · Microorganisms
  74. COVID-19 Salivary Protein Profile: Unravelling Molecular Aspects of SARS-CoV-2 Infection
    Eduardo Esteves, Vera M. Mendes, Bruno J. Manadas, Rafaela Lopes, Liliana Inácio Bernardino, Maria José Correia, Marlene Barros, Ana Cristina Esteves, Nuno das Neves Rosa · 2022 · Journal of Clinical Medicine
  75. Delineating the SARS-CoV-2 Induced Interplay between the Host Immune System and the DNA Damage Response Network
    Christina Papanikolaou, Vasiliki Rapti, Dimitris Stellas, Dimitra T. Stefanou, Konstantinos Syrigos, George N. Pavlakis, Vassilis L. Souliotis · 2022 · Vaccines
  76. SARS-CoV-2: analysis of the effects of mutations in non-structural proteins
    Kavya Senthilazhagan, Seshagiri Sakthimani, Deepthi Kallanja, Sangita Venkataraman · 2023 · Archives of Virology
  77. Does SARS-CoV-2 Induce IgG4 Synthesis to Evade the Immune System?
    Alberto Rubio‐Casillas, Elrashdy M Moustafa Mohamed Redwan, Vladimir Nikolaevich Uversky · 2023 · Biomolecules
  78. Brain Pathology in COVID-19: Clinical Manifestations and Potential Mechanisms
    Zhixing Xu, Hui Wang, Siya Jiang, Jiao Teng, Dongxu Zhou, Zhong Chen, Chengping Wen, Zhenghao Xu · 2023 · Neuroscience Bulletin
  79. Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis
    Li Wang, María Guzman, Diego Muñoz‐Santos, José M. Honrubia, Jorge Ripoll-Gómez, Rafael Bastos Delgado, Isabel Sola, Luis Enjuanes, Sonia Zúñiga · 2023 · Frontiers in Cellular and Infection Microbiology
  80. SARS-CoV-2 infection in immunosuppression evolves sub-lineages which independently accumulate neutralization escape mutations
    Gila Lustig, Yashica Ganga, Hylton E. Rodel, Houriiyah Tegally, Afrah Khairallah, Laurelle Jackson, Sandile Cele, Khadija Khan, Zesuliwe Jule, Kajal Reedoy et al. · 2023 · Virus Evolution
  81. SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination
    Nicola Manfrini, Samuele Notarbartolo, Renata Grifantini, Elisa Pesce · 2024 · Antibodies
  82. Insight into the emerging role of SARS-CoV-2 nonstructural and accessory proteins in modulation of multiple mechanisms of host innate defense
    Abualgasim Elgaili Abdalla, Jianping Xie, Kashaf Junaid, Sonia Younas, Tilal Elsaman, Khalid Omer Abdalla Abosalif, Ayman Ali Mohammed Alameen, Mahjoob Osman Mahjoob, Mohammed Yagoub Mohammed Elamir, Hasan Ejaz · 2021 · Bosnian Journal of Basic Medical Sciences
  83. COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variants
    Felix Wussow, Mindy Kha, Katelyn Faircloth, Vu H. Nguyen, Angelina Iniguez, Joy Martinez, Yoonsuh Park, Jenny Nguyen, Swagata Kar, Hanné Andersen et al. · 2022 · iScience
  84. Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective
    Varun Aggarwal, Ekta Bala, Pawan Kumar, Pankaj Raizada, Pardeep Singh, Praveen Kumar Verma · 2023 · Current Topics in Medicinal Chemistry
  85. Severe COVID-19versusmultisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection
    Rupsha Fraser, Aurelio Orta Resendiz, David Harold Dockrell, Michaela C. Müller-Trutwin, Alexander Mazein · 2023 · European Respiratory Review
  86. Transcriptomic analysis of sorted lung cells revealed a proviral activity of the NF-κB pathway toward SARS-CoV-2
    Anvita Bhargava, Ugo Szachnowski, Maxime Chazal, Dominika Foretek, Vincent Caval, Sophie‐Marie Aicher, Juliana Pipoli da Fonseca, Patricia Jeannin, Guillaume Beauclair, Marc Monot et al. · 2023 · iScience
  87. Quantitative comparison of nuclear transport inhibition by SARS coronavirus ORF6 reveals the importance of oligomerization
    Tae Yeon Yoo, Timothy John Mitchison · 2024 · Proceedings of the National Academy of Sciences
  88. SARS-CoV-2 Orf6 is positioned in the nuclear pore complex by Rae1 to inhibit nucleocytoplasmic transport
    Tadashi Makio, Ke Zhang, Nicole Love, Fred David Mast, Xue Liu, Mohamed Elaish, Tom C. Hobman, John D. Aitchison, Beatriz M. A. Fontoura, Richard W. Wozniak · 2024 · Molecular Biology of the Cell
  89. SARS-CoV-2 infection modifies the transcriptome of the megakaryocytes in the bone marrow
    Isabelle Allaeys, Guillaume Lemaire, Mickaël Leclercq, Émile Lacasse, Maude Fleury, Isabelle Dubuc, Leslie Gudimard, Florian Puhm, Julia Tilburg, Andrew P. Stone et al. · 2024 · Blood Advances
  90. Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication
    Shiori Ueno, Sodbayasgalan Amarbayasgalan, Yoshiro Sugiura, Tatsuki Takahashi, Kenta Shimizu, Keisuke Nakagawa, Reika Kawabata‐Iwakawa, Wataru Kamitani · 2024 · Virology
  91. Harnessing the power of IFN for therapeutic approaches to COVID-19
    Elise G. Viox, Steven E. Bosinger, Daniel C. Douek, Gideon Schreiber, Mirko Paiardini · 2024 · Journal of Virology
  92. Coronavirus nucleocapsid protein enhances the binding of p-PKCα to RACK1: Implications for inhibition of nucleocytoplasmic trafficking and suppression of the innate immune response
    Wenxiang Xue, Hongyan Chu, Jiehuang Wang, Yingjie Sun, Xusheng Qiu, Cuiping Song, Lei Tan, Chan Ding, Ying Liao · 2024 · PLoS Pathogens
  93. Strategies for the Viral Exploitation of Nuclear Pore Transport Pathways
    Xin Zhang, Keesiang Lim, Yujia Qiu, Masaharu Hazawa, Richard Wing-Chuen Wong · 2025 · Viruses
  94. Roles of antiviral sensing and type I interferon signaling in the restriction of SARS-CoV-2 replication
    Elizabeth Geerling, Amanda N. Pinski, E. Taylor Stone, Richard J. DiPaolo, Michael Z. Zulu, Kevin J. Maroney, James D. Brien, Ilhem Messaoudi, Amelia K. Pinto · 2021 · iScience
  95. Interferons in coronavirus pathogenesis: The good, the bad, and the ugly
    Rudragouda Channappanavar · 2022 · Cell Host & Microbe
  96. Roles of RNA Sensors in Host Innate Response to Influenza Virus and Coronavirus Infections
    Wei Li, Hongnuan Wang, Shijun J. Zheng · 2022 · International Journal of Molecular Sciences
  97. Sequencing during Times of Change: Evaluating SARS-CoV-2 Clinical Samples during the Transition from the Delta to Omicron Wave
    Shuchen Feng, Mudassir S. Ali, Monika Evdokimova, Gail Reid, Nina M. Clark, Susan L. Uprichard, Susan C. Baker · 2022 · Viruses
  98. Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants
    Jing Xing, Rama Shankar, Meehyun Ko, Keke Zhang, Sulin Zhang, Aleksandra K. Drelich, Shreya Paithankar, Eugene Chekalin, Mei‐Sze Chua, Surender Rajasekaran et al. · 2022 · iScience
  99. On the Evolutionary Trajectory of SARS-CoV-2: Host Immunity as a Driver of Adaptation in RNA Viruses
    Jacob Warger, Silvana Gaudieri · 2022 · Viruses
  100. Surface air gas discharge plasma: An ecofriendly virus inactivation approach to enhance CPRRs mediated antiviral genes expression against airborne bio-contaminant (human Coronavirus-229E)
    Paritosh Patel, Neha Kaushik, Tirtha Raj Acharya, Eun Ha Choi, Nagendra Kumar Kaushik · 2024 · Environmental Pollution